Related Experiment Videos
Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease
Clinical Endocrinology
|March 1, 1977
Summary
Thyroid-stimulating immunoglobulins (TSI) were found in 43% of patients with ophthalmic Graves' disease. Some TSI antibodies were biologically inactive, while others controlled thyroid function, preventing hyperthyroidism through autoimmune thyroid destruction.
Area of Science:
- Endocrinology
- Immunology
- Ophthalmology
Background:
- Graves' disease is an autoimmune disorder often associated with ophthalmic complications.
- Thyroid-stimulating immunoglobulins (TSI) are autoantibodies implicated in the pathogenesis of Graves' disease.
Purpose of the Study:
- To investigate the prevalence and biological activity of TSI in patients with ophthalmic Graves' disease.
- To correlate TSI detection by receptor assay with thyroid function and clinical presentation.
Main Methods:
- Sera from patients with ophthalmic Graves' disease were analyzed for TSI using a receptor assay.
- Thyroid function tests were performed and compared with TSI assay results.
Main Results:
- Thyroid-stimulating immunoglobulins (TSI) were detected in 43% of patients with ophthalmic Graves' disease.
- A subset of detected TSI antibodies demonstrated biological inactivity.
- In other patients, TSI appeared to regulate thyroid function, with autoimmune thyroid destruction potentially preventing hyperthyroidism.
Conclusions:
- The presence of TSI in ophthalmic Graves' disease is significant, but biological activity varies.
- TSI may play a complex role in disease progression, influencing thyroid status and potentially mediating protective autoimmune mechanisms.